Phastar and Medrio have been partnering together on trials for the past 3 years, culminating in a unique way to visualize clinical trial data. Through the use of Medrio’s API, Phastar has built a data visualization tool that reduces risk and allows for complete study oversight. In this podcast we’ll discuss the need for data visualization in clinical trials, how Phastar has continued their trials during a global pandemic, and what their thoughts are on the future of how we collect and view data.
Australia and New Zealand have not been impacted as much as North America and the EU with regards to COVID-19. For this reason, and...
Welcome to the Trial Talks podcast, a thought-provoking show about clinical research. On this podcast, we will be exploring trends in the industry as...
Approximately 39.5% of all men and women will be diagnosed with cancer at some point during their lifetimes, and yet only 8% of oncology...